The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...